Question 1

What is Philip J. Mease?

Accepted Answer

Philip J. Mease is a Person.

Question 2

How often does Philip J. Mease appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Philip J. Mease first tracked by Ergen?

Accepted Answer

First tracked on May 28, 2026.

Question 4

When was Philip J. Mease last mentioned in news?

Accepted Answer

Last active on May 29, 2026.

Question 5

What is Philip J. Mease's current news sentiment?

Accepted Answer

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Philip J. Mease in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Philip J. Mease?

Accepted Answer

FDA approves TREMFYA label expansion (May 28, 2026, 6 articles).

Question 8

How did the "FDA approves TREMFYA label expansion" event impact Philip J. Mease?

Accepted Answer

Philip J. Mease, Director of Rheumatology Research at Swedish Medical Center/Providence St. Joseph Health, offered an expert opinion on the importance of Guselkumab's label expansion for patients.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.